|
Volumn 209, Issue 2, 2010, Pages 213-215
|
BDNF plasma levels decrease during benzodiazepine withdrawal in patients suffering from comorbidity of depressive disorder and benzodiazepine dependence
|
Author keywords
BDNF; Benzodiazepine dependence; Benzodiazepine withdrawal; Comorbidity; Depression; GDNF
|
Indexed keywords
BENZODIAZEPINE;
BRAIN DERIVED NEUROTROPHIC FACTOR;
GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR;
BENZODIAZEPINE DERIVATIVE;
BIOLOGICAL MARKER;
ARTICLE;
CLINICAL ARTICLE;
COMORBIDITY;
CONTROLLED STUDY;
DEPRESSION;
DISEASE ASSOCIATION;
DRUG DEPENDENCE;
DRUG EFFECT;
HUMAN;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
PROTEIN DETERMINATION;
PROTEIN EXPRESSION;
BLOOD;
CASE CONTROL STUDY;
DOWN REGULATION;
LETTER;
WITHDRAWAL SYNDROME;
BENZODIAZEPINES;
BIOLOGICAL MARKERS;
BRAIN-DERIVED NEUROTROPHIC FACTOR;
CASE-CONTROL STUDIES;
DEPRESSIVE DISORDER;
DOWN-REGULATION;
GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR;
HUMANS;
SUBSTANCE WITHDRAWAL SYNDROME;
|
EID: 77952763890
PISSN: 00333158
EISSN: 14322072
Source Type: Journal
DOI: 10.1007/s00213-010-1781-3 Document Type: Article |
Times cited : (12)
|
References (8)
|